Mandatory notification of trade in Vistin Pharma ASA

August 27, 2023 Off By GlobeNewswire

Ferncliff Listed DAI AS has on 25 August 2023 purchased 200,000 shares in Vistin Pharma ASA at NOK 21 per share. After the transaction Ferncliff Listed DAI AS has a holding of 1,234,280 shares, corresponding to 2,78% ownership. Ferncliff Listed DAI AS is closely associated with board member Øystein Stray Spetalen.
Attachment

20230825_Notification of trade_Ferncliff i Vistin